Search for: "Ortho-McNeil Pharmaceutical"
Results 101 - 120
of 270
Sort by Relevance
|
Sort by Date
1 May 2011, 2:02 pm
Caraco, concerning Patent Use Codes, and Ortho-McNeil v. [read post]
20 Apr 2011, 8:27 am
Topamax birth defect lawsuits claim that the manufacturer - Ortho-McNeil-Janssen Pharmaceuticals - knew or should have know that Topamax caused these birth defects in children. [read post]
20 Apr 2011, 8:27 am
Topamax birth defect lawsuits claim that the manufacturer - Ortho-McNeil-Janssen Pharmaceuticals - knew or should have know that Topamax caused these birth defects in children. [read post]
18 Apr 2011, 1:12 pm
Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets. [read post]
18 Apr 2011, 12:40 pm
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called the "package insert" or "label") for its Ortho Evra (norelgestromin/ ethinyl estradiol) transdermal system to give a stronger warning about blood clot related side effects like… [read post]
13 Apr 2011, 5:13 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
23 Mar 2011, 5:02 am
(Thanks again to Bloomberg.com and these reporters for the coverage).J&J’s Risperdal Letter Violated Consumer Law, Jury Finds By Jef Feeley and Gary Henderson - Mar 22, 2011 7:23 PM ETA Johnson & Johnson (JNJ) unit violated consumer-protection laws by sending South Carolina doctors a misleading letter about the safety and effectiveness of the antipsychotic drug Risperdal, a jury concluded.Jurors in state court in Spartanburg, South Carolina, deliberated more than six hours before… [read post]
22 Mar 2011, 8:34 am
” In fact, in May 2010, Ortho-McNeil Pharmaceutical LLC pleaded guilty to illegal promotion of Topamax and was sentenced to pay a criminal fine of over $6 million. [read post]
22 Mar 2011, 5:08 am
(Thanks to Bloomberg.com for the coverage).J&J Duped South Carolina Doctors Over Risperdal, Lawyer Says By Jef Feeley and Gary Henderson - Mar 21, 2011 5:38 PM ETJohnson & Johnson executives deceived South Carolina doctors about the safety of the antipsychotic drug Risperdal, and the drugmaker should be held liable for that deception, a lawyer said.J&J made misleading claims about Risperdal’s health risks and effectiveness in a letter to more than 7,000 South Carolina doctors and… [read post]
8 Mar 2011, 7:54 am
Topamax is an Ortho-McNeil and Johnson & Johnson product. [read post]
21 Feb 2011, 7:46 am
In May of 2010, Ortho McNeil Pharmaceutical, LLC, a subsidiary of Johnson & Johnson, pled guilty in U.S. [read post]
7 Feb 2011, 6:53 pm
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
6 Jan 2011, 9:46 pm
It was a big blow to Johnson & Johnson and its subsidiary, Ortho-McNeil-Janssen Pharmaceuticals, to have lost their first Levaquin trial to 82-year-old John Schedin, having to pay him more than $1 million dollars in damages. [read post]
10 Dec 2010, 3:45 am
Image by Ricky Romero via FlickrYesterday a jury in Minneapolis today awarded a verdict in the case of John Schedin, who sued J&J and its Ortho-McNeil-Janssen Pharmaceuticals unit in 2008. [read post]
1 Dec 2010, 12:15 am
Apotex, Inc (Patently-O) Simcor (Niacin/Simvastatin) – US: Impax Laboratories confirms patent challenge relating to Simcor extended-release tablets (SmartBrief) Taxotere (Docetaxel) – EU: Actavis launches Docetaxel single vial on patent expiry in major European markets (GenericsWeb) Temodar (Temozolide) – US: Cancer Research Technology files patent infringement suit against Accord following Para IV certification filing (Patent Docs) Tri-Cyclen Lo (Norgestimate/ethinyl estradiol)… [read post]
24 Nov 2010, 10:57 am
Schedin, the plaintiff, as well as Johnson & Johnson and its Ortho-McNeil-Janssen Pharmaceutical unit made there opening argurments to the jury. [read post]
17 Nov 2010, 1:48 am
(Patently-O) US: Amicus brief filed by Alnylam Pharmaceuticals argues that Funk Bros. is about obviousness, not patent eligibility: AMP v USPTO (Holman’s Biotech IP Blog) US: Amicus briefs in AMP v USPTO: Genetic Alliance (Patent Docs) US: Patent expirations will stabilise the pharmaceutical industry (BiotechBlog) US: Generic industry headed for a ‘180-day exclusivity cliff’ (FDA Law Blog) US: PTO clarifies PTE availability in post-PhotoCure and… [read post]
10 Nov 2010, 6:22 am
Cir. 2010) and Ortho-McNeil Pharm., Inc. v. [read post]
27 Oct 2010, 1:00 pm
In the United States, after successfully defending several Paragraph IV challenges to the enforceability of molecule patent US5053407 ('407), Ortho-McNeil recently won an injunction to prevent Lupin from infringement during the extended term for this patent, which is assigned to Daiichi Sankyo but exclusively licensed to Ortho-McNeil. [read post]
7 Oct 2010, 12:35 pm
Ortho McNeil Pharmaceutical, Inc introduced the Ortho Evra birth control patch in 2002. [read post]
